CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
Authors: Bookman, Michael A | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | July 22, 2022 | PubMed abstract
